NCT07260708 Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers Status RECRUITING Phase PHASE1
NCT06649656 A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06413953 A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors Status RECRUITING Phase PHASE1
NCT05380882 Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers Status UNKNOWN Phase PHASE1
NCT05333276 Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers Status UNKNOWN Phase PHASE1
NCT03726333 Hepatic Impairment Study for Lorlatinib in Cancer Patients Status TERMINATED Phase PHASE1
NCT02873975 A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency Status COMPLETED Phase PHASE2
NCT02801045 Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient Status COMPLETED Phase NA
NCT02668770 Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies Status TERMINATED Phase PHASE1
NCT02623959 Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis Status TERMINATED Phase PHASE4
NCT02597478 Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea Status COMPLETED Phase PHASE2/PHASE3
NCT02571036 A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02561234 A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02523378 Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion Status COMPLETED Phase NA
NCT02514252 Sublingual Fentanyl for the Management of Breakthrough Pain Status TERMINATED Phase PHASE2